Bharat Biotech's COVID-19 vaccine Covaxin has been approved for emergency use on children between the ages of 12 and 18 by the Drugs Controller General of India (DCGI). India will start rolling out vaccines for children between 15 and 18 years from January 3, but no data has been made public yet.